257 related articles for article (PubMed ID: 10857787)
1. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level.
Pelletier JP; Jovanovic DV; Lascau-Coman V; Fernandes JC; Manning PT; Connor JR; Currie MG; Martel-Pelletier J
Arthritis Rheum; 2000 Jun; 43(6):1290-9. PubMed ID: 10857787
[TBL] [Abstract][Full Text] [Related]
2. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase.
Pelletier JP; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Di Battista JA; Martel-Pelletier J
Arthritis Rheum; 1998 Jul; 41(7):1275-86. PubMed ID: 9663486
[TBL] [Abstract][Full Text] [Related]
3. Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase.
Pelletier JP; Fernandes JC; Jovanovic DV; Reboul P; Martel-Pelletier J
J Rheumatol; 2001 Nov; 28(11):2509-19. PubMed ID: 11708426
[TBL] [Abstract][Full Text] [Related]
4. Licofelone (ML-3000), a dual inhibitor of 5-lipoxygenase and cyclooxygenase, reduces the level of cartilage chondrocyte death in vivo in experimental dog osteoarthritis: inhibition of pro-apoptotic factors.
Boileau C; Martel-Pelletier J; Jouzeau JY; Netter P; Moldovan F; Laufer S; Tries S; Pelletier JP
J Rheumatol; 2002 Jul; 29(7):1446-53. PubMed ID: 12136904
[TBL] [Abstract][Full Text] [Related]
5. The in situ up-regulation of chondrocyte interleukin-1-converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide.
Boileau C; Martel-Pelletier J; Moldovan F; Jouzeau JY; Netter P; Manning PT; Pelletier JP
Arthritis Rheum; 2002 Oct; 46(10):2637-47. PubMed ID: 12384922
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors.
Pelletier JP; Lascau-Coman V; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Martel-Pelletier J
J Rheumatol; 1999 Sep; 26(9):2002-14. PubMed ID: 10493683
[TBL] [Abstract][Full Text] [Related]
7. Oral treatment with PD-0200347, an alpha2delta ligand, reduces the development of experimental osteoarthritis by inhibiting metalloproteinases and inducible nitric oxide synthase gene expression and synthesis in cartilage chondrocytes.
Boileau C; Martel-Pelletier J; Brunet J; Tardif G; Schrier D; Flory C; El-Kattan A; Boily M; Pelletier JP
Arthritis Rheum; 2005 Feb; 52(2):488-500. PubMed ID: 15693013
[TBL] [Abstract][Full Text] [Related]
8. Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis.
Pelletier JP; Lajeunesse D; Jovanovic DV; Lascau-Coman V; Jolicoeur FC; Hilal G; Fernandes JC; Martel-Pelletier J
J Rheumatol; 2000 Dec; 27(12):2893-902. PubMed ID: 11128682
[TBL] [Abstract][Full Text] [Related]
9. In vivo selective inhibition of mitogen-activated protein kinase kinase 1/2 in rabbit experimental osteoarthritis is associated with a reduction in the development of structural changes.
Pelletier JP; Fernandes JC; Brunet J; Moldovan F; Schrier D; Flory C; Martel-Pelletier J
Arthritis Rheum; 2003 Jun; 48(6):1582-93. PubMed ID: 12794826
[TBL] [Abstract][Full Text] [Related]
10. Reduction in the structural changes of experimental osteoarthritis by a nitric oxide inhibitor.
Pelletier J; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Martel-Pelletier J
Osteoarthritis Cartilage; 1999 Jul; 7(4):416-8. PubMed ID: 10419785
[TBL] [Abstract][Full Text] [Related]
11. The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1, and oncogene protein synthesis in experimental osteoarthritis.
Pelletier JP; DiBattista JA; Raynauld JP; Wilhelm S; Martel-Pelletier J
Lab Invest; 1995 May; 72(5):578-86. PubMed ID: 7745952
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, reduces the progression of experimental osteoarthritis in guinea pigs.
Kobayashi T; Notoya K; Naito T; Unno S; Nakamura A; Martel-Pelletier J; Pelletier JP
Arthritis Rheum; 2005 Feb; 52(2):479-87. PubMed ID: 15692987
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic effects of tenidap in canine experimental osteoarthritis: relationship with biochemical markers.
Jovanovic D; Caron JP; Martel-Pelletier J; Fernandes JC; Ricketts T; Pelletier JP
J Rheumatol; 1997 May; 24(5):916-25. PubMed ID: 9150082
[TBL] [Abstract][Full Text] [Related]
14. Licofelone reduces progression of structural changes in a canine model of osteoarthritis under curative conditions: effect on protease expression and activity.
Moreau M; Boileau C; Martel-Pelletier J; Brunet J; Laufer S; Pelletier JP
J Rheumatol; 2006 Jun; 33(6):1176-83. PubMed ID: 16652435
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of inducible nitric oxide synthase results in reductions in wound vascular endothelial growth factor expression, granulation tissue formation, and local perfusion.
Howdieshell TR; Webb WL; Sathyanarayana ; McNeil PL
Surgery; 2003 May; 133(5):528-37. PubMed ID: 12773981
[TBL] [Abstract][Full Text] [Related]
16. Selective iNOS-inhibition does not influence apoptosis in ruptured canine cranial cruciate ligaments.
Hofer D; Forterre S; Schweighauser A; Krayer M; Doherr M; Schawalder P; Zurbriggen A; Spreng D
Vet Comp Orthop Traumatol; 2009; 22(3):198-203. PubMed ID: 19448875
[TBL] [Abstract][Full Text] [Related]
17. Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: an immunohistochemical study.
Fernandes JC; Martel-Pelletier J; Lascau-Coman V; Moldovan F; Jovanovic D; Raynauld JP; Pelletier JP
J Rheumatol; 1998 Aug; 25(8):1585-94. PubMed ID: 9712105
[TBL] [Abstract][Full Text] [Related]
18. The peroxisome proliferator-activated receptor gamma agonist pioglitazone reduces the development of cartilage lesions in an experimental dog model of osteoarthritis: in vivo protective effects mediated through the inhibition of key signaling and catabolic pathways.
Boileau C; Martel-Pelletier J; Fahmi H; Mineau F; Boily M; Pelletier JP
Arthritis Rheum; 2007 Jul; 56(7):2288-98. PubMed ID: 17599749
[TBL] [Abstract][Full Text] [Related]
19. Colon epithelial cell death in 2,4,6-trinitrobenzenesulfonic acid-induced colitis is associated with increased inducible nitric-oxide synthase expression and peroxynitrite production.
Yue G; Lai PS; Yin K; Sun FF; Nagele RG; Liu X; Linask KK; Wang C; Lin KT; Wong PY
J Pharmacol Exp Ther; 2001 Jun; 297(3):915-25. PubMed ID: 11356911
[TBL] [Abstract][Full Text] [Related]
20. Oral treatment with a Brachystemma calycinum D don plant extract reduces disease symptoms and the development of cartilage lesions in experimental dog osteoarthritis: inhibition of protease-activated receptor 2.
Boileau C; Martel-Pelletier J; Caron J; Paré F; Troncy E; Moreau M; Pelletier JP
Ann Rheum Dis; 2010 Jun; 69(6):1179-84. PubMed ID: 19546097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
